Patents Assigned to PML Screening, LLC
  • Patent number: 11913073
    Abstract: This document provides methods and materials related to treating a disease. For example, this document provides methods for treating a subject's disease based on identifying the risk of progressive multifocal leukoencephalopathy PML using a genetic test.
    Type: Grant
    Filed: March 16, 2023
    Date of Patent: February 27, 2024
    Assignees: PML Screening, LLC, The Université Paris-Saclay, The Assistance Publique—Hôpitaux de Paris (APHP), The Institut National de la Santé et de la Recherche Médicale (INSERM)
    Inventors: Eli Hatchwell, Peggy S. Eis, Edward B. Smith, III, Yassine Taoufik
  • Patent number: 11913074
    Abstract: This document provides methods and materials related to treating a disease. For example, this document provides methods for treating a subject's disease based on identifying the risk of progressive multifocal leukoencephalopathy PML using a genetic test.
    Type: Grant
    Filed: March 17, 2023
    Date of Patent: February 27, 2024
    Assignees: PML Screening, LLC, The Université Paris-Saclay, The Assistance Publique—Hôpitaux de Paris (APHP), The Institut National de la Santé et de la Recherche Médicale (INSERM)
    Inventors: Eli Hatchwell, Peggy S. Eis, Edward B. Smith, III, Yassine Taoufik
  • Patent number: 10961585
    Abstract: This document provides methods and materials related to treating a disease. For example, this document provides methods for treating a subject's disease based on identifying the risk of progressive multifocal leukoencephalopathy PML using a genetic test.
    Type: Grant
    Filed: August 15, 2019
    Date of Patent: March 30, 2021
    Assignees: PML Screening, LLC, The Université Paris-Suclay, The Assistance Publique—Hopitaux de Paris (APHP), The Institut National de la Sante et de la Recherche Medicale
    Inventors: Eli Hatchwell, Peggy S. Eis, Edward B. Smith, III, Yassine Taoufik
  • Patent number: 10941448
    Abstract: This document provides methods and materials related to treating a disease. For example, this document provides methods for treating a subject's disease based on identifying the risk of progressive multifocal leukoencephalopathy PML using a genetic test.
    Type: Grant
    Filed: January 11, 2019
    Date of Patent: March 9, 2021
    Assignees: The Universite Paris-Saclay, The Assistance Publique-Hopitaux de Paris (APHP), The Institut National de la Sante et de la Recherche Medicale (INSERM), PML Screening, LLC
    Inventors: Eli Hatchwell, Peggy S. Eis, Edward B. Smith, III, Yassine Taoufik
  • Patent number: 10563264
    Abstract: This document provides methods and materials related to treating a disease. For example, this document provides methods for treating a subject's disease based on identifying the risk of progressive multifocal leukoencephalopathy PML using a genetic test.
    Type: Grant
    Filed: August 16, 2019
    Date of Patent: February 18, 2020
    Assignees: PML Screening, LLC, The Universite Paris-Sud, The Assistance Publique—Hopitaux de Paris (APHP), The Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Eli Hatchwell, Peggy S. Eis, Edward B. Smith, III, Yassine Taoufik
  • Patent number: 10544463
    Abstract: This document provides methods and materials related to treating a disease. For example, this document provides methods for treating a subject's disease based on identifying the risk of progressive multifocal leukoencephalopathy PML using a genetic test.
    Type: Grant
    Filed: August 20, 2019
    Date of Patent: January 28, 2020
    Assignees: PML Screening, LLC, The Universite Paris-Sud, The Assistance Publique—Hopitaux de Paris (APHP), The Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Eli Hatchwell, Peggy S. Eis, Edward B. Smith, III, Yassine Taoufik
  • Patent number: 10240205
    Abstract: This document provides methods and materials related to treating a disease. For example, this document provides methods for treating a subject's disease based on identifying the risk of progressive multifocal leukoencephalopathy PML using a genetic test.
    Type: Grant
    Filed: June 30, 2017
    Date of Patent: March 26, 2019
    Assignees: Population Bio, Inc., The Universite Paris-Sud, The Assistance Publique—Hopitaux de Paris (APHP), The Institut National de la Sante et de la Recherche Medicale (INSERM), PML Screening, LLC
    Inventors: Eli Hatchwell, Peggy S. Eis, Edward B. Smith, III, Yassine Taoufik